CVI Holdings »

Regulus Therapeutics shares owned by CVI Holdings

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by CVI Holdings from 13F filings

Historical chart of CVI Holdings investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by CVI Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by CVI Holdings

Quarter filed Position value Share count Share price at filing
2024-06-30 $716k 401k 1.79
2024-03-31 $4.1M 1.4M 2.88

More positions owned by CVI Holdings

Flutter Entmt SHS (FLUT)
Oatly Group Ab Note 9.250% 9/1 (Principal)
Skye Bioscience Com New (SKYE)
Inmune Bio Ord (INMB)
Gp-act Iii Acquisition Corp Unit 99/99/9999 (GPATU)
AZZ Incorporated (AZZ)
Flag Ship Acquisition Corp Unit 05/22/2029 (FSHPU)
Ib Acquisition Corp Com Shs (IBAC)
Haymaker Acquisition Corp Iv Class A (HYAC)
Agriculture & Nat Sol Acq Shs Cl A (ANSC)
Iron Horse Acquisitions Corp (IROH)
Bayview Acquisition Corp Ord Shs (BAYA)
Trailblazer Merger Corp I Cl A (TBMC)
Nyxoah S A SHS (NYXH)
Goldenstone Acq Crp; Tnt Acq Dt: 12/21/2023; Cash: $10.15 (GDST)

View all positions for CVI Holdings

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics